首页|Ribonucleotide reductase M2(RRM2):Regulation,function and targeting strategy in human cancer

Ribonucleotide reductase M2(RRM2):Regulation,function and targeting strategy in human cancer

扫码查看
Ribonucleotide reductase M2(RRM2)is a small subunit in ribonucleotide reduc-tases,which participate in nucleotide metabolism and catalyze the conversion of nucleotides to deoxynucleotides,maintaining the dNTP pools for DNA biosynthesis,repair,and replication.RRM2 performs a critical role in the malignant biological behaviors of cancers.The structure,regulation,and function of RRM2 and its inhibitors were discussed.RRM2 gene can produce two transcripts encoding the same ORF.RRM2 expression is regulated at multiple levels during the processes from transcription to translation.Moreover,this gene is associated with resistance,regulated cell death,and tumor immunity.In order to develop and design inhibitors of RRM2,appropriate strategies can be adopted based on different mechanisms.Thus,a greater appre-ciation of the characteristics of RRM2 is a benefit for understanding tumorigenesis,resistance in cancer,and tumor microenvironment.Moreover,RRM2-targeted therapy will be more atten-tion in future therapeutic approaches for enhancement of treatment effects and amelioration of the dismal prognosis.

FunctionInhibitionRegulationResistanceRRM2

Zanwen Zuo、Zerong Zhou、Yuzhou Chang、Yan Liu、Yuping Shen、Qizhang Li、Lei Zhang

展开 >

Innovative Drug R&D Center,College of Life Sciences,Huaibei Normal University,Huaibei,Anhui 235000,China

National"111"Center for Cellular Regulation and Molecular Pharmaceutics,Key Laboratory of Fermentation Engineering(Ministry of Education),Hubei Key Laboratory of Industrial Microbiology,Cooperative Innovation Center of Industrial Fermentation(Ministry of Education & Hubei Province),and School of Food and Biological Engineering,Hubei University of Technology,Wuhan,Hubei 430068,China

Department of Biomedical Informatics,The Ohio State University,Columbus,OH 43210,USA

School of Agriculture and Biology,and Engineering Research Center of Cell & Therapeutic Antibody,Ministry of Education,Shanghai Jiao Tong University,Shanghai 200240,China

College of Chemistry and Bioengineering,Hunan University of Science and Engineering,Yongzhou,Hunan 425199,China

Department of Pharmaceutical Botany,School of Pharmacy,Naval Medical University,Shanghai 200433,China

展开 >

Guiding Project of Science and Technology Research Program of the Hubei Provincial Department of Education(China)Collaborative Grantin-Aid of the HBUT National"111"Center for Cellular Regulation and Molecular Pharmaceutics(China)Open Project Funding of the Key Laboratory of Fermentation Engineering(Ministry of Education,China)Hubei University of Technology(China)

B2020048XBTK-2021006202105FE02BSQD2020038

2024

基因与疾病(英文)

基因与疾病(英文)

ISSN:
年,卷(期):2024.11(1)
  • 216